The Singapore Biopolis – What’s Next

 

Dr. Benjamin SeetAudience

On April 28, Dr. Benjamin Seet, Executive Director of the Biomedical Research Council, Agency for Science, Technology and Research addressed the Healthcare Committee on what to expect in the coming 5 years. Tracing Singapore’s journey into the biomedical sciences, Dr Seet described the factors which led Singapore to diversify into this area and illustrated the emphasis of the recently announced RIE2020 tranche. Totaling SGD 19 billion, the RIE2020 plan will be focused on 4 domains; with a significant focus on translating research to healthcare outcomes.

Co-Chairs

Christopher Hall

Christopher Hall

FitBit Pte Ltd

Jeff Weisel

Jeff Weisel

Ernst & Young

Join the Committee

About

Healthcare Committee

The Committee promotes and represents the healthcare industry in Singapore and the region by helping to shape healthcare policy, providing a channel for communication between members and government, and providing a platform for information sharing among various sectors, including service provision, pharmaceuticals, and medical device and equipment manufacturers.
Upcoming and Recent Committee Meetings